TCL Archive Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive? September 28, 2012
TCL Archive Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing November 1, 2012
TCL Archive Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s January 17, 1992